MOLLY PARKTON: Open Payments
NPI 1811614159 · FORT WALTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 44 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $285 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $191 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Amgen Inc. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| ABBVIE INC. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Lilly USA, LLC | 2 | $40 |
Products named: Ozempic, TRELEGY ELLIPTA, EVENITY, XIFAXAN, CAPLYTA, Kerendia, GEMTESA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
